Baystate Wealth Management’s Invesco International Dividend Achievers ETF PID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$38.1K Buy
2,066
+11
+0.5% +$188 ﹤0.01% 424
2023
Q3
$34.4K Buy
2,055
+20
+1% +$355 ﹤0.01% 393
2023
Q2
$36.8K Buy
2,035
+18
+0.9% +$324 ﹤0.01% 369
2023
Q1
$36K Buy
2,017
+21
+1% +$368 ﹤0.01% 380
2022
Q4
$33K Buy
1,996
+9
+0.5% +$148 ﹤0.01% 396
2022
Q3
$30K Buy
1,987
+20
+1% +$344 ﹤0.01% 376
2022
Q2
$34K Buy
1,967
+21
+1% +$389 ﹤0.01% 370
2022
Q1
$38K Buy
+1,946
New +$36.7K ﹤0.01% 366
2013
Q3
Sell
-2,408
Closed -$39K 177
2013
Q2
$39K Buy
+2,408
New +$41K 0.02% 114

Other funds holding PID

Baystate Wealth Management's PID Position: Q4 2023 in Review

Baystate Wealth Management increased its Invesco International Dividend Achievers ETF (PID) stake by 0.54% in Q4 2023, buying an estimated $188 and bringing the position to 2,066 shares worth $38.1K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Baystate Wealth Management first reported a position in PID in Q2 2013 and has held it in 9 quarters since. The position peaked at $39K in Q2 2013. 158 funds tracked by Wall St. Rank hold PID as of Q4 2023.

  • Baystate Wealth Management held 2,066 shares of Invesco International Dividend Achievers ETF worth $38.1K as of Q4 2023.
  • Baystate Wealth Management bought 11 Invesco International Dividend Achievers ETF shares in Q4 2023, an estimated $188.
  • Invesco International Dividend Achievers ETF made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #424 holding.
  • Baystate Wealth Management first reported a position in Invesco International Dividend Achievers ETF in Q2 2013 and has held it in 9 quarters since.
  • Baystate Wealth Management's Invesco International Dividend Achievers ETF position peaked at $39K in Q2 2013.
  • 158 funds tracked by Wall St. Rank held Invesco International Dividend Achievers ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.